DMDiah Kurnia Mirawati

Diah Kurnia Mirawati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diah Kurnia Mirawati has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparing therapeutic effects of Qur’anic recitation and classical music in vascular cognitive impairment: a case series

    by Ira Ristinawati, Tyasno Koeshermanto, Muhammad Hafizhan, Stefanus Erdana Putra, Muhammad Naufal Rafif, Suyatmi, Pepi Budianto, Suroto, Diah Kurnia Mirawati, Subandi, et al.

    The increasing prevalence of vascular cognitive impairment (VCI) underscores the critical need for innovative non-pharmacological strategies. This retrospective comparative case series evaluated the effects of classical music therapy, Qur’anic recitation, and their combination on cognitive function and religious engagement in 7 patients with VCI due to rare disorders, including vasculitis related to systemic lupus erythematosus and Balint syndrome. Assessments included brain magnetic resonance imaging, the Indonesian version of the Montreal Cognitive Assessment, the dementia solat score, and C-reactive protein levels. Patients who received only Qur’anic recitation demonstrated the most significant improvement in cognitive function and religious engagement. The findings suggest that Qur’anic recitation therapy has yielded superior results despite potential sound wave conflicts. Future studies with larger samples are required to validate these findings and explore further non-pharmacological interventions for VCI.

  • Open Access

    Factors associated with quality of life in patients with epilepsy: a preliminary path analysis of psychological and neurobiological determinants

    by Diah Kurnia Mirawati, Ihsan Hanif, Muhammad Hafizhan, Stefanus Erdana Putra, Hanindia Riani Prabaningtyas, Yetty Hambarsari, Muthmainah Muthmainah, Intan Permatasari, Indana Zulfa Zakiah, Pepi Budianto

    Background: Epilepsy significantly impacts various aspects of a patient’s life, extending beyond seizure control to encompass their overall well-being and quality of life. Understanding the complex interplay of direct factors, such as seizure frequency and medication side effects, alongside indirect factors like psychological distress and social support, is crucial for developing comprehensive interventions aimed at improving the lives of individuals living with epilepsy. This study aimed to determine the direct and indirect effects of anxiety, depression, and seizure frequency on the quality of life of patients with epilepsy using path analysis. Methods: This was an observational analytic study with a cross-sectional design. A total of 32 patients with primary epilepsy were recruited from the Neurology Clinic at Universitas Sebelas Maret Hospital. The mean age of the participants was 35.43 ± 14.00 years. Quality of life was assessed using the Indonesian Quality of Life in Epilepsy Inventory-10 (QOLIE-10). Anxiety and depression were measured with the Generalized Anxiety Disorder 7-item (GAD-7) and the Hamilton Depression Rating Scale (HDRS), respectively. Blood samples were used to measure cortisol and brain-derived neurotrophic factor (BDNF) levels. Path analysis was conducted in Stata 13.0 for Windows to model the hypothesized direct and indirect relationships among variables. Model fit was evaluated using Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and absolute fit indices. Results: Path analysis revealed a significant negative direct association between BDNF levels and QOLIE-10 scores (B = −0.072, p = 0.017), indicating that higher BDNF levels are associated with improved quality of life, as reflected in lower distress scores. Conversely, seizure frequency (B = 0.23, p = 0.039) and GAD-7 scores (B = 0.70, p < 0.001) were positively associated with QOLIE-10, indicating that increased seizures and anxiety are linked to poorer quality of life. Indirect effects were also identified, with seizure frequency positively influencing both GAD-7 (B = 0.56, p < 0.001) and HDRS scores (B = 0.39, p = 0.002), which, in turn, are significant contributors to a reduced quality of life. The model demonstrated a good fit, with an AIC of 1,272.185 and a BIC of 1,315.064. Conclusions: Managing seizures is not only critical for reducing the direct burden of epilepsy but also essential for mitigating anxiety and depression, which are significant contributors to a reduced quality of life. Our findings underscore the importance of a holistic care approach that addresses seizure control and psychological well-being.

  • Open Access

    Bibliometric mapping of secretomes, exosomes, and extracellular vesicles in Alzheimer’s disease

    by Yetty Hambarsari, Suroto Suroto, Diah Kurnia Mirawati, Soetrisno Soetrisno, Paramasari Dirgahayu, Brian Wasita, Vitri Widyaningsih

    Context: Alzheimer’s Disease (AD) is a neurodegenerative disorder with limited treatment options, primarily addressing symptoms without targeting underlying mechanisms. Emerging therapies involving secretomes, exosomes, and extracellular vesicles (EVs) show promise in modulating AD pathology, including amyloid-beta accumulation, tau aggregation, and neuroinflammation. Aims: To conduct a bibliometric analysis of global research on secretomes, exosomes, and EVs in AD to identify trends, key contributors, and future research directions. Methods: A bibliometric analysis was conducted using the Scopus database. A total of 988 studies were identified based on English-language and final publication-stage studies, reviews, and conference papers. The data were analyzed using Scopus tools, the bibliometrics R package (Biblioshiny), and VOSviewer to evaluate publication trends, key contributors, and keyword co-occurrence networks. Results: Research on secretomes, exosomes, and EVs in AD has grown steadily from 2003 to 2025, with a significant increase in publications since 2010. The studies span 397 sources, with an annual growth rate of 6.5% and a high average citation rate per article (65.55). Key topics included fundamental mechanisms (e.g., neuroinflammation, amyloid-beta, tauopathy), biomarker development, and therapeutic approaches. Emerging areas requiring further exploration include clinical applications (e.g., delivery systems), novel biomarkers (e.g., gut–brain axis indicators), and advanced analytical methods (e.g., machine learning, bioinformatics). Conclusions: This study reveals an expanding global interest in the role of secretomes, exosomes, and EVs in AD. It identifies significant trends and research gaps, emphasizing the need for translational efforts that bridge experimental insights and clinical applications. Future efforts should focus on translating promising findings into clinical applications while addressing underexplored topics and fostering international collaboration.


  • Open Access

    Bromodomain‐containing protein 2 gene polymorphism among patients with photosensitive epilepsy in Indonesia

    by Diah Kurnia Mirawati, Muhana Fawwazy Ilyas, Muhammad Hafizhan, Stefanus Erdana Putra, Suroto Suroto, Subandi Subandi, Rivan Danuaji, Pepi Budianto, Yetty Hambarsari, Baarid Luqman Hamidi, et al.

    Objectives: Genetic‐associated epilepsy in the Indonesian population is rarely discussed, and no study was specifically studied about photosensitive epilepsy. The fundamental goal of this research endeavor was to evaluate whether the single nucleotide polymorphism (SNP) of the Bromodomain‐Containing Protein 2 (BRD2) gene gives vulnerability to photosensitive epilepsy among Indonesian descent.Methods: This observational case–control study includes patients of Indonesian descent with Javanese ancestry. Clinical and neurophysiological data, along with electroencephalographic (EEG) recordings, were used to diagnose epilepsy and photosensitive epilepsy. Blood samples were collected and analyzed for BRD2 gene SNPs (rs206781, rs188245, and rs15912) using polymerase chain reaction (PCR), electrophoresis, and the Sanger sequencing method.Results: This study included 27 participants, consisting of 17 patients in the epilepsy group (nine patients with photosensitive epilepsy and eight patients without photosensitive epilepsy) and 10 patients in the non‐epilepsy group. Significant statistical differences were found in genotype (rs206781, p = 0.008 and rs188245, p = 0.004) and allele frequencies (rs206781, p < 0.001 and rs188245, p < 0.001) of the BRD2 gene in Indonesian descent with Javanese race patients diagnosed with photosensitive epilepsy and in those without this condition.Significance: Our study corroborates the observation that genetic diversity within the BRD2 locus (rs206781 and rs188245) is associated with PE in Indonesian descendants of the Javanese race. To acquire a complete knowledge of the development of photosensitive epilepsy, further polymorphism studies at other SNP locations or genes are necessary.Plain Language Summary: This study investigated whether genetic differences in the BRD2 gene were linked to photosensitive epilepsy (a type of epilepsy triggered by visual stimuli like flashing lights) in individuals of Indonesian Javanese descent. We analyzed deoxyribonucleic acid (DNA) samples from patients with epilepsy, including those with photosensitive epilepsy, and found that certain variations in the BRD2 gene were significantly more common in people with photosensitive epilepsy. These findings imply that genetic factors, specifically variations in the BRD2 gene, could elevate the risk of individuals in this population experiencing photosensitive epilepsy.

  • Open Access

    Correlation between lipid profile and cognitive function deterioration in ischemic stroke patients

    by Diah Kurnia Mirawati, Pepi Budianto, Hanindia R. Prabaningtyas, Subandi Subandi, Rivan Danuaji, Ira Ristinawati, Raden A.A. Tedjo, Indana Z. Zakiah, Stefanus E. Putra, Muhammad Hafizhan

    Context: The second most common type of dementia is vascular dementia, caused by cerebrovascular disease. The decline in cognitive function after ischemic stroke occurs with varying degrees of severity and onset. This variability is attributed to the overlapping neurodegenerative and vascular damage. Aims: To investigate the correlation between lipid profile, a biomarker of vascular dysfunction, and cognitive function in ischemic stroke patients. Methods: A total of 52 respondents (mean age 64.21 ± 9.78 years) were recruited, and the Spearman correlation test found a moderate positive correlation (r=0.658, p=0.04) between lipid profile and cognitive function deterioration. The ordinal regression analysis was used to calculate the odds ratio (OR). Results: The results showed that the OR for cognitive function deterioration associated with high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, and total cholesterol were -1.54 (95% CI -0.98 - -3.46, p=0.002), 1.78 (95% CI 1.27-2.46, p=0.000), 2.48 (95% CI 1.39-4.92, p=0.04), and 1.54 (95% CI 1.04-2.48, p=0.003) respectively. Conclusion: Based on the results, a positive correlation with moderate strength was observed between lipid profile and cognitive function deterioration in ischemic stroke patients.

  • Open Access

    AI-Enhanced Biosignal Analysis for Obstructive Sleep Apnea Detection: A Comprehensive Review

    by Aida Noor Indrawati, Nuryani Nuryani, Wiharto, Diah Kurnia Mirawati

    Obstructive sleep apnea (OSA) detection using single-lead electrocardiograms (ECGs) has advanced significantly with the integration of artificial intelligence (AI). This review explores how AI enhances feature extraction and machine learning algorithms to improve OSA detection. The RR interval in electrocardiographic data is particularly valued for its ease of identification and low error rate. We review a range of machine learning and deep learning techniques employed in OSA detection. This review offers insights into developing single-lead ECG-based OSA detection systems by analyzing database availability, feature extraction methods, and machine learning approaches.


  • Open Access

    Correlation of electrolytes with falling risk, cognitive function, and functional outcome in acute ischemic stroke patient

    by Diah Kurnia Mirawati, Ira Ristinawati, Hanindia Riani Prabaningtyas, Raden Andi Ario Tedjo, Stefanus Erdana Putra, Muhammad Hafizhan, Rudi Ilhamsyah

    Stroke outcome is determined on multiple factors. However, there are limited studies discussing the impact of electrolyte imbalance on stroke outcome. In this study, we analyzed sodium, calcium, and potassium level in acute ischemic stroke, and compare their risk of falling, cognitive function, and functional outcome. This was a cross-sectional study in Dr. Moewardi General Hospital, Indonesia between January and June 2023. Patient with acute ischemic stroke were enrolled in this study. Cognitive function was assessed with mini mental state examination (MMSE) and the Indonesian version of montreal cognitive assessment (MoCA-Ina). National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (MRS) and Morse Fall Score (MFS) were used to assessed stroke severity, disability, and risk of falling, respectively. Pearson correlation was then performed to evaluate the correlation of electrolytes level with MMSE, MoCA-Ina, NIHSS, MRS, and MFS. Furthermore, we also analyzed the odds ratio of increasing risk of falling, cognitive function deterioration, and worse functional outcome. A p-value of <0.05 is considered statistically significant. On univariate analysis, natrium is correlated with MMSE (r=0.174; p=0.042), NIHSS (r=-0.412; p=0.011), MRS (r=-0.174; p=0.042), and MFS (r=-0.304; p=0.042). Potassium is correlated with MMSE (r=0.344; p=0.044), MoCA-INA (r=0.341; p=0.048), NIHSS (r=-0.572; p=0.019), (MRS r=-0.376; p=0.017), and MFS (r=-0.612; p=0.031). Calcium is correlated with NIHSS r=-0.348 (p=0.018), MRS r=-0.256 (p=0.036). On odds ratio analysis, low natrium level increased the risk of deteriorating cognitive function, and low level of potassium increased the risk of falling. Electrolyte imbalances correlates with risk of falling and deteriorating cognitive function.

  • Open Access

    A Systematic Review of Secretome-Based Therapies for Alzheimer's Disease: Bridging the Preclinical and Clinical Gap

    by Yetty Hambarsari, Suroto Suroto, Diah Kurnia Mirawati, Soetrisno Soetrisno, Brian Wasita, Vitri Widyaningsih, Eti Poncorini Pamungkasari, Subandi Subandi, Rivan Danuaji, Baarid Luqman Hamidi, et al.

    Background: Alzheimer's Disease (AD) is a progressive neurodegenerative disorder with a rapidly increasing prevalence. Current therapeutic options primarily manage symptoms, not modifying the disease. Secretome-based therapies have emerged as a promising avenue for AD treatment in targeting multiple pathways and promoting neuroprotection and regeneration. This systematic review evaluated the preclinical and clinical evidences for secretome-based therapies in AD.Methods: A systematic search was conducted across Scopus, PubMed, ScienceDirect, and Cochrane Library. The SYRCLE risk of bias (RoB) tool was used for preclinical studies and Cochrane RoB 2.0 for clinical studies. We performed qualitative analysis of study results.Results: Included 21 in vivo studies and 2 clinical trials revealed promising outcomes of treatments involving secretomes, exosomes, and extracellular vesicles from different cell sources. The therapies could reduce amyloid plaque load, reactive gliosis, and enhance neuronal density. These findings suggested the treatments reveal mechanism of action in neuroprotection, neuroregeneration, and inflammation modulation, which are critical in AD pathology. Ongoing trials also supported the safety and efficacy of the treatment strategies. However, translational medical study faces several challenges regarding large-scale production, optimization of protocols, and understanding biomarkers. The heterogeneity in secretome-based therapies administration have complicated the comparison of study outcomes and the translation of preclinical findings into clinical settings. Deeper understanding of the secretome's mechanisms of action, optimal dosing, and delivery methods are needed to maximize therapeutic outcomes.Conclusion: Despite secretome-based therapies hold significant promise for AD treatment, addressing the identified gaps and limitations is crucial for advancing these therapies from preclinical research to clinical practice.


  • Open Access

    Research productivity in catamenial epilepsy: A bibliometric analysis of worldwide scientific literature (1956–2022)

    by Diah Kurnia Mirawati, Nanang Wiyono, Muhana Fawwazy Ilyas, Stefanus Erdana Putra, Muhammad Hafizhan


  • Open Access

    The effect of listening to Holy Quran recitation on stress among healthy adults: a non-blinded randomized controlled trial

    by Muchtar Hanafi, Arif Rahmatillah, Nanang Wiyono, Diah Kurnia Mirawati

    Universa Medicina is a four-monthly medical journal that publishes new research findings on a wide variety of topics of importance to biomedical science and clinical practice